Status:
COMPLETED
Biomarkers algOrithm for strOke diagnoSis and Treatment Resistance Prediction
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Stroke, Ischemic
Large Vessel Occlusion
Eligibility:
All Genders
18+ years
Brief Summary
Triage of acute ischemic stroke (AIS) patients is critical, to decrease time to treatment, and improve functional outcome. The therapeutic standard of care for AIS consecutive to large vessel occlusio...
Eligibility Criteria
Inclusion
- Symptoms consistent with stroke \<24 hours
- Adult patients ≥ 18 years old
- Non opposition of the patient or his/her relatives to the research (emergency inclusion procedure)
Exclusion
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
March 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2025
Estimated Enrollment :
3880 Patients enrolled
Trial Details
Trial ID
NCT04726839
Start Date
March 12 2021
End Date
July 10 2025
Last Update
September 16 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Department Neurology Caen Hospital
Caen, France
2
Lariboisière
Paris, France, 75010
3
Rothschild Foundation Hospital
Paris, France
4
Hospital Foch
Suresnes, France